The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 07, 2019
Filed:
Dec. 22, 2016
Applicant:
Abbvie Deutschland Gmbh & Co. KG, Weisbaden, DE;
Inventors:
Wilhelm Amberg, Ludwigshafen, DE;
Udo Lange, Ludwigshafen, DE;
Herve Geneste, Ludwigshafen, DE;
Michael Ochse, Ludwigshafen, DE;
Ralf Biesinger, Ludwigshafen, DE;
Frank Oellien, Ludwigshafen, DE;
Assignee:
ABBVIE DEUTSCHLAND GMBH & CO. KG, Wiesbaden, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/12 (2006.01); C07D 205/04 (2006.01); C07C 229/48 (2006.01); C07C 229/46 (2006.01); C07D 211/62 (2006.01); C07D 261/12 (2006.01); C07D 209/52 (2006.01); C07D 207/16 (2006.01); C07D 207/08 (2006.01); C07D 265/36 (2006.01); C07C 59/72 (2006.01); C07D 405/04 (2006.01); C07D 311/04 (2006.01); C07D 405/14 (2006.01); C07D 311/58 (2006.01); C07C 229/30 (2006.01); C07C 229/36 (2006.01); C07C 229/50 (2006.01); C07D 207/06 (2006.01); C07D 265/38 (2006.01); C07D 209/94 (2006.01); C07D 211/32 (2006.01);
U.S. Cl.
CPC ...
C07D 413/12 (2013.01); C07C 59/72 (2013.01); C07C 229/30 (2013.01); C07C 229/36 (2013.01); C07C 229/46 (2013.01); C07C 229/48 (2013.01); C07C 229/50 (2013.01); C07D 205/04 (2013.01); C07D 207/06 (2013.01); C07D 207/08 (2013.01); C07D 207/16 (2013.01); C07D 209/52 (2013.01); C07D 209/94 (2013.01); C07D 211/32 (2013.01); C07D 211/62 (2013.01); C07D 261/12 (2013.01); C07D 265/36 (2013.01); C07D 265/38 (2013.01); C07D 311/04 (2013.01); C07D 311/58 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07C 2601/04 (2017.05); C07C 2601/14 (2017.05); C07C 2602/10 (2017.05); C07C 2602/38 (2017.05);
Abstract
The invention relates to (hetero)cyclic compounds as S1P modulators, pharmaceutical compositions comprising such compounds, and uses thereof in the treatment, alleviation or prevention of diseases or disorders mediated by an S1P receptor.